Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Other 1Gastrointestinal 1

Conditions

Urologic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Obesity 1Neuromuscular Blockade 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Sugammadex × Clear all
NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Korea University Anam Hospital

Phase 3 Completed
196 enrolled 11 charts
GastrointestinalOther

Obesity, Stomach Neoplasms

NCT03210376 2020-11-25

Neuromuscular Blockade on Shoulder Pain of Elderly

M.D. Anderson Cancer Center

Phase 4 Completed
100 enrolled 17 charts
Genitourinary

Urologic Neoplasms

NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed
54 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

NCT03039543 2018-05-22

Neuromuscular Blockade During Transurethral Resection of Bladder Cancer

Seoul National University Bundang Hospital

Phase 4 Completed
108 enrolled 8 charts

Neuromuscular Blockade

Data powered by HemOnc (CC BY 4.0) Colophon âš¡